CN
EN
Home
Technology
Products
Recombinant Human Serum Albumin
Reagent Grade (Recombinant Human Serum Albumin, HyWill)
Excipient Grade (Recombinant Human Serum Albumin)
Cell Culture Grade (Recombinant Human Serum Albumin)
Recombinant Growth factors
Recombinant Human Epidermal Growth Factor (rhEGF)
Recombinant Human Basic Fibroblast Growth Factor (OsrhbFGF)
Recombinant Human Insulin-like Growth Factor-1 LR3 (rhIGF-1 LR3)
Recombinant Human Vascular Endothelial Growth Factor (OsrhVEGF)
Recombinant Human Keratinocyte Growth Factor (OsrhKGF)
Proteins for Cosmetics Ingredients
Recombinant Human basic Fibroblast Growth Factor (OsrhbFGF)
Recombinant Human Epidermal Growth Factor (rhEGF)
Recombinant Human Vascular Endothelial Growth Factor (OsrhVEGF)
Recombinant Human Keratinocyte Growth Factor (OsrhKGF)
Recombinant Human Lactoferrin (OsrhLF)
Recombinant Human Fibronectin (OsrhFN)
Recombinant Human Lysozyme (OsrhLYZ)
Other Recombinant Proteins
Recombinant Human Transferrin (HyCreat, OsrhTF)
Recombinant Human Lactoferrin (OsrhLF)
Recombinant Human Fibronectin (OsrhFN)
Recombinant Human Lysozyme (OsrhLYZ)
Recombinant Human α-1 Antitrypsin (OsrhAAT)
Services
Recombinant Protein Expression
Purification Process Development
Detection Methodology Service
Company
About us
Development
R&D Team
Careers
News
Events
Contact
FAQ
Company info
Feedback
Privacy policy
Home
Technology
Products
Recombinant Human Serum Albumin
Reagent Grade (Recombinant Human Serum Albumin, HyWill)
Excipient Grade (Recombinant Human Serum Albumin)
Cell Culture Grade (Recombinant Human Serum Albumin)
Recombinant Growth factors
Recombinant Human Epidermal Growth Factor (rhEGF)
Recombinant Human Basic Fibroblast Growth Factor (OsrhbFGF)
Recombinant Human Insulin-like Growth Factor-1 LR3 (rhIGF-1 LR3)
Recombinant Human Vascular Endothelial Growth Factor (OsrhVEGF)
Recombinant Human Keratinocyte Growth Factor (OsrhKGF)
Proteins for Cosmetics Ingredients
Recombinant Human basic Fibroblast Growth Factor (OsrhbFGF)
Recombinant Human Epidermal Growth Factor (rhEGF)
Recombinant Human Vascular Endothelial Growth Factor (OsrhVEGF)
Recombinant Human Keratinocyte Growth Factor (OsrhKGF)
Recombinant Human Lactoferrin (OsrhLF)
Recombinant Human Fibronectin (OsrhFN)
Recombinant Human Lysozyme (OsrhLYZ)
Other Recombinant Proteins
Recombinant Human Transferrin (HyCreat, OsrhTF)
Recombinant Human Lactoferrin (OsrhLF)
Recombinant Human Fibronectin (OsrhFN)
Recombinant Human Lysozyme (OsrhLYZ)
Recombinant Human α-1 Antitrypsin (OsrhAAT)
Services
Recombinant Protein Expression
Purification Process Development
Detection Methodology Service
Company
About us
Development
R&D Team
Careers
News
Events
Contact
FAQ
Company info
Feedback
Privacy policy
About us
Development
R&D Team
Careers
News
Events
Plant-derived Recombinant Human Serum Albumin Injection (HY1001 project) Clinical Trials Phase II Data Progress Report
September 26th, China Health Ecology Organization (CHEO) was grandly held in Bo’ao. At the Pharmaceutical Innovation and Capital Market sub-forum of the China Pharmaceutical Innovation Ecological conference (CPIE), which is the one of the six core summits of CHEO, Professor...
Posted by Site editor
|
2021-09-27
LearnMore
The Global Premiere of Clinical trial Phase I data of recombinant human lactoferrin and Lysozyme Oral Solution (Project HY1002)
September 25, 2021, the 6th “China Biomed Innovation and Investment Conference” was successfully held in Suzhou. As the star session of the conference, the Global Premiere of Clinical Data session attracted much attention from all walks of life. This year, there are n...
Posted by Site editor
|
2021-09-26
LearnMore
The Starting Ceremony of the Construction of Plant-derived Recombinant Human Serum Albumin of 1 Million Vials Production Line Project
February 19th, 2021, the 8th day of the first lunar year, Wuhan Healthgen Biotechnology Corp. (Hereinafter referred to as "Healthgen Biotech") had the starting ceremony of the construction of plant-derived recombinant human serum albumin core technology resear...
Posted by Site editor
|
2021-02-19
LearnMore
The World Premiere of Clinical trial Phase I data of recombinant human serum albumin independently developed by Healthgen Biotech
September 27, 2020, the world’s first plant-derived recombinant human serum albumin (OsrHSA) independently developed by Wuhan Healthgen Biotechnology Corp. (Healthgen Biotech) was presented to the world, publicly released the clinical trial phase I data in humans in the Uni...
Posted by Site editor
|
2020-09-27
LearnMore
Healthgen Biotech project HY1002 clinical trials phase I kick-off meeting was successfully held
September 2, 2020, the kick-off meeting of " clinical trials phase I project of recombinant human lactoferrin and lysozyme oral liquid (Project No. HY1002) " was successfully held in the Affiliated Hospital of Guizhou Medical University, marking the official entry of th...
Posted by Site editor
|
2020-09-03
LearnMore
Pre
1
2
3
4
5
6
Next
Copyright ® Wuhan Healthgen Biotechnology Corp. All rights reserved. Terms and Conditions of Use
鄂ICP备12013293号-3
Tel
Tel:027-59403931 Ext 8015
BBS